Related Experiment Video

Updated: Aug 20, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.4K

Oral Antiviral Treatment for COVID-19: A Comprehensive Review on Nirmatrelvir/Ritonavir

Karolina Akinosoglou1, Georgios Schinas1, Charalambos Gogos1

  • 1Department of Internal Medicine, Medical School, University of Patras, 26504 Rio, Greece.

Viruses
|November 24, 2022
PubMed

Insights

Oral nirmatrelvir coupled with ritonavir (NMV/r) effectively treats early COVID-19 in high-risk adults. Real-world data confirm its safety and efficacy against variants, reducing hospitalizations.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Virology

Background:

  • The COVID-19 pandemic necessitates effective outpatient treatments.
  • Early intervention is crucial due to SARS-CoV-2 viral kinetics.
  • Oral antiviral agents offer a promising treatment avenue.

Purpose of the Study:

  • To evaluate the efficacy and safety of nirmatrelvir coupled with ritonavir (NMV/r) for early COVID-19 treatment.
  • To assess NMV/r's impact on disease progression in high-risk adult populations.
  • To review real-world data on NMV/r's effectiveness against SARS-CoV-2 variants.

Main Methods:

  • Analysis of real-world data on NMV/r treatment in adult COVID-19 patients.
  • Assessment of NMV/r's efficacy in preventing disease progression and hospitalization.
  • Review of safety profiles and viral rebound occurrences post-treatment.

Main Results:

  • Nirmatrelvir coupled with ritonavir (NMV/r) demonstrates efficacy in preventing COVID-19 progression in high-risk adults.
  • Real-world data support the safety and effectiveness of NMV/r against all viral variants of concern.
  • NMV/r has significantly reduced hospitalizations and disease severity.

Conclusions:

  • Nirmatrelvir coupled with ritonavir (NMV/r) is a valuable tool in managing COVID-19, preventing severe outcomes.
  • Further research is needed on potential resistance related to the Mpro gene and on future NMV/r development.
  • Increased awareness and research are warranted for optimal utilization of NMV/r in pandemic control.
Keywords:
COVID-19PaxlovidSARS-CoV-2nirmatrelvirnirmatrelvir/ritonavirritonavirtreatment

More Related Videos

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

17.9K
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

13.9K

Related Concept Videos

Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
76
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.6K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
384
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.5K
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
334
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
130